Dr. Amir Lerman presents "The Use of Lp-PLA2 in the Clinical Setting in Prediction of CV Events" Click here to view.
Dr. Renu Virmani presents "The Role of Lp-PLA2 in Vascular Inflammation and Rupture Prone Plaque" Click here to view
Lp-PLA2 Mechanism of Action
Lp-PLA2 levels identify cardiovascular disease (CVD) risk assessment independent from other biomarkers - providing insight into the relationship between inflammation, atherosclerosis and CV outcomes.
View the Lp-PLA2 Mechanism of Action.
- No items found.